Free Trial
ASX:MDC

Medlab Clinical (MDC) Stock Price, News & Analysis

Medlab Clinical logo

About Medlab Clinical Stock (ASX:MDC)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Medlab Clinical Faces Steep Revenue Decline and Loss
Child Care on College Campuses: What to Know
Crypto’s hidden gem + greatest crypto bull run in history = $$$?
You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.
Clinical Laboratory Technician Salary
See More Headlines

MDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Medlab Clinical investors own include Magellan Financial Group (MFG), iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1) and Bod Australia (BDA).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Construction
CIK
N/A
Fax
N/A
Employees
1,640
Year Founded
N/A

Profitability

Net Income
$-3,940,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$-1,470,000.00
Book Value
A($0.31) per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.89
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (ASX:MDC) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners